Literature DB >> 6278015

Pituitary gigantism in a 31 month old girl: endocrine studies and successful response to hypophysectomy.

E A Espiner, T A Carter, G D Abbott, P Wrightson.   

Abstract

A case of pituitary gigantism occurring in a 31 month old female child is reported. Growth records indicate that the disorder began early in the second yr of life. Apart from her size and history of excessive sweating, there were no characteristic clinical features of endocrinopathy. Elevated and autonomous secretion of GH (60-109 microgram/l) and prolactin were corrected by the removal of an eosinophilic pituitary adenoma. In the subsequent 6 yr, despite the presence of immunoreactive GH (4.6-17.3 microgram/l), plasma somatomedin was subnormal and the patient showed growth failure which responded normally to exogenous GH therapy. This case, which appears to be the youngest example of verified pituitary gigantism on record, illustrates that a successful outcome can be achieved by surgical ablative therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6278015     DOI: 10.1007/BF03348309

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  A rapid method for measuring 17-hydroxycorticosteroids in urine.

Authors:  M G METCALF
Journal:  J Endocrinol       Date:  1963-06       Impact factor: 4.286

2.  Roentgen standards fo-size of the pituitary fossa from infancy through adolescence.

Authors:  F N SILVERMAN
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1957-09

3.  The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids.

Authors:  I J DREKTER; A HEISLER; G R SCISM; S STERN; S PEARSON; T H McGAVACK
Journal:  J Clin Endocrinol Metab       Date:  1952-01       Impact factor: 5.958

4.  Measurement of pituitary hormones: clinical applications. 5. Prolactin.

Authors:  R A Donald; E A Espiner; S C Hodgkinson; K Evans
Journal:  N Z Med J       Date:  1976-06-23

5.  Pituitary gigantism. A case report and review.

Authors:  E D Haigler; J M Hershman; C K Meador
Journal:  Arch Intern Med       Date:  1973-10

6.  Measurement of pituitary hormones: clinical applications. 1. Luteinising hormone.

Authors:  R A Donald
Journal:  N Z Med J       Date:  1972-04

7.  Evidence for "big" and "little" components of human plasma and pituitary growth hormone.

Authors:  P Gorden; C M Hendricks; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

8.  Charcoal-dextran radioimmunoassay of human growth hormone.

Authors:  M S Wool; H A Selenkow
Journal:  Acta Endocrinol (Copenh)       Date:  1968-01

9.  Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.

Authors:  T W AvRuskin; K Sau; S Tang; C Juan
Journal:  J Clin Endocrinol Metab       Date:  1973-09       Impact factor: 5.958

10.  Radioimmunoassay for human follicle-stimulating hormone: physiological studies.

Authors:  W D Odell; A F Parlow; C M Cargille; G T Ross
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

View more
  6 in total

1.  Hereditary pituitary hyperplasia with infantile gigantism.

Authors:  Sven Gläsker; Alexander O Vortmeyer; Antony R A Lafferty; Paul L Hofman; Jie Li; Robert J Weil; Zhengping Zhuang; Edward H Oldfield
Journal:  J Clin Endocrinol Metab       Date:  2011-10-05       Impact factor: 5.958

2.  Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.

Authors:  J Flitsch; D K Lüdecke; N Stahnke; J Wiebel; W Saeger
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

Review 3.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

4.  Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

Authors:  Giampaolo Trivellin; Adrian F Daly; Fabio R Faucz; Bo Yuan; Liliya Rostomyan; Darwin O Larco; Marie Helene Schernthaner-Reiter; Eva Szarek; Letícia F Leal; Jean-Hubert Caberg; Emilie Castermans; Chiara Villa; Aggeliki Dimopoulos; Prashant Chittiboina; Paraskevi Xekouki; Nalini Shah; Daniel Metzger; Philippe A Lysy; Emanuele Ferrante; Natalia Strebkova; Nadia Mazerkina; Maria Chiara Zatelli; Maya Lodish; Anelia Horvath; Rodrigo Bertollo de Alexandre; Allison D Manning; Isaac Levy; Margaret F Keil; Maria de la Luz Sierra; Leonor Palmeira; Wouter Coppieters; Michel Georges; Luciana A Naves; Mauricette Jamar; Vincent Bours; T John Wu; Catherine S Choong; Jerome Bertherat; Philippe Chanson; Peter Kamenický; William E Farrell; Anne Barlier; Martha Quezado; Ivana Bjelobaba; Stanko S Stojilkovic; Jurgen Wess; Stefano Costanzi; Pengfei Liu; James R Lupski; Albert Beckers; Constantine A Stratakis
Journal:  N Engl J Med       Date:  2014-12-03       Impact factor: 91.245

5.  Pathological and experimental investigations in a case of gigantism.

Authors:  I Fazekas; E Pásztor; F Slowik; K Bálint; I Dobronyi; E Bácsy; A Gyévai; F Péter; L Blatniczky; I Varga
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.

Authors:  I A Felix; E Horvath; K Kovacs; H S Smyth; D W Killinger; J Vale
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.